Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George Lau et al.|Hepatology International|2020Cited by 295
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levelsMilan J. Sonneveld, Benjamin Maasoumy, Shao‐Ming Chiu et al.|Journal of Hepatology|2022Cited by 121
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular RiskEugene Han, Seung Up Kim, Yong‐ho Lee et al.|The American Journal of Gastroenterology|2020Cited by 112
Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)Milan J. Sonneveld, Benjamin Maasoumy, Jun Yong Park et al.|Clinical Gastroenterology and Hepatology|2020Cited by 103
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populationsHiromi Sawai, Katsushi Tokunaga, Nao Nishida et al.|BMC Medical Genetics|2012Cited by 41